Results of a phase III study investigating lenalidomide combined with chemoimmunotherapy for first line treatment of diffuse large b-cell lymphoma in patients 80 years or older.
Home / Resource Library / Adding Lenalidomide to R-miniCHOP Does Not Improve OS in Older Adults With DLBCL